Browsing publications by Dr Deborah Stocken

Newcastle AuthorsTitleYear
Dr Deborah Stocken
Phase 1 trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients2013
Dr Deborah Stocken
Dr Thamir Ismail
Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test2012
Dr Deborah Stocken
The value of source data verification in a cancer clinical trial2012
Dr Deborah Stocken
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-132011
Dr Deborah Stocken
Adjuvant Chemotherapy with Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection: a Randomized Controlled Trial2010
Dr Deborah Stocken
Statistical Modelling for the Prognostic Classification of Patients with Pancreatic Cancer for Optimisation of Treatment Allocation [PhD Thesis]2010
Dr Deborah Stocken
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials2009
Dr Deborah Stocken
ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma2009
Dr Thamir Ismail
Dr Deborah Stocken
Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme2009
Dr Deborah Stocken
Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer - subset analysis of the ESPAC-1 data2009
12345